Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)

Net Debt

$686.70M

Quarterly · Period ending: · USD

BIO logo

BIO Net Debt

Latest reported$686.70M
BIO Quarterly Net Debt ($18.90M → $686.70M)
High-resolution chart · PNG

BIO net debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bio-Rad Laboratories, Inc. Class A Common Stock Net Debt — Quarterly (USD)
Period endingNet Debt (USD)
686,700,000
871,000,000
999,200,000
997,500,000
1,037,200,000
848,100,000
886,600,000
977,738,000
985,758,000
966,459,000
1,001,628,000
947,621,000
992,251,000
917,577,000
953,883,000
861,011,000
795,080,000
601,861,000
-247,407,000
-624,077,000
-510,035,000
-442,408,000
-436,470,000
-194,994,000
38,160,000
44,841,000
-9,489,000
104,823,000
80,440,000
210,481,000
7,904,000
6,058,000
37,491,000
27,775,000
51,177,000
106,033,000
113,307,000
143,092,000
-21,744,000
16,495,000
15,700,000
30,661,000
-23,368,000
-71,222,000
-14,205,000
10,197,000
22,724,000
12,617,000
52,662,000
72,836,000
105,850,000
145,453,000
367,494,000
365,655,000
270,776,000
306,082,000
276,350,000
198,896,000
158,281,000
61,375,000
62,393,000
113,575,000
57,730,000
112,095,000
129,866,000
145,632,000
93,113,000
189,854,000
210,854,000
257,592,000
251,033,000
264,637,000
271,724,000
328,643,000
295,668,000
-41,744,000
198,366,000
199,799,000
205,060,000
191,100,000
184,705,000
164,169,000
132,312,000
190,817,000
185,211,000
117,567,000
239,702,000
109,312,000
80,756,000
93,153,000
170,863,000
94,060,000
83,517,000
84,785,000
85,521,000
110,259,000
134,918,000
139,492,000
151,225,000
178,949,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.